Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M101,614Revenue (TTM) $M37,776Net Margin (%)5.8Altman Z-Score1.4
Enterprise Value $M122,232EPS (TTM) $0.4Operating Margin %12.4Piotroski F-Score7
P/E(ttm)45.8Beneish M-Score-2.8Pre-tax Margin (%)10.1Higher ROA y-yY
Price/Book44.610-y EBITDA Growth Rate %-1.8Quick Ratio0.6Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %-8.8Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow15.4y-y EBITDA Growth Rate %40.0ROA % (ttm)2.9Higher Current Ratio y-yN
Dividend Yield %4.8PEG--ROE % (ttm)132Less Shares Outstanding y-yN
Payout Ratio %235Shares Outstanding M4,918ROIC % (ttm)13.5Gross Margin Increase y-yY

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

GLAXF is held by these investors:



GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$22-5.91view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14-2.08view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29291.3view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1272.5view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1447.86view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1272.5view

Quarterly/Annual Reports about GLAXF:

    News about GLAXF:

    Articles On GuruFocus.com
    What Financial Modeling Says About Gilead Sciences Jul 26 2017 
    GSK ships 2017-18 seasonal influenza vaccines for US market Jul 14 2017 
    Vaccine Small-Cap Just Took a Big Step Forward Jun 26 2017 
    GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine S Jun 21 2017 
    VBI Vaccines Just Took a Major Step Forward in Its HBV Program Jun 21 2017 
    DarioHealth: Disruption Is Valuable Jun 07 2017 
    Kahn Brothers Buys BlackBerry, Novartis, Assured Guaranty May 31 2017 
    Seth Klarman Backs Out of Innoviva Days After Activist Stakeholder Defeated May 10 2017 
    Pernix: An Investor's Rationale to Staying Long Mar 23 2017 
    Jeff Auxier Reduces, Exits Multiple Positions in 4th Quarter Mar 22 2017 

    More From Other Websites
    [$$] Glaxo Slashes R&D Projects to Focus on Top Prospects Jul 26 2017
    GlaxoSmithKline's new boss streamlines R&D, axes slew of drugs Jul 26 2017
    Glaxo Looks Beyond the Lab Jul 26 2017
    Glaxo CFO Says Prioritizing R&D for Product Growth Jul 26 2017
    Drugmaker GSK calls for at least two years' Brexit transition Jul 26 2017
    Glaxo (GSK) Beats Q2 Earnings, Misses Sales Jul 26 2017
    Glaxo reports 2Q loss Jul 26 2017
    Drugmaker GSK reviewing its R&D programs under new CEO Jul 26 2017
    GlaxoSmithKline on the Street: Analyst Recommendations after 2Q17 Jul 26 2017
    GSK Stock Falls on Reduced Guidance Jul 26 2017
    Unpacking GlaxoSmithKline’s 2Q17 Revenue Expectations Jul 25 2017
    Inside GlaxoSmithKline’s 2Q17 Earnings Estimates Jul 25 2017
    Drug Stocks Q2 Earnings Releases on Jul 26: GILD, VRTX, GSK Jul 25 2017
    GlaxoSmithKline Names Former Walmart Exec as New CTO Jul 25 2017
    GSK hires ex-Wal-Mart executive to transform tech operations Jul 25 2017
    Corporate News Blog - GlaxoSmithKline and Innoviva Submits EU Filing for Extended Use of Relvar... Jul 25 2017
    Gilead's HIV Drug Matches Glaxo Rival In Late-Stage Trials Jul 24 2017
    The Zacks Analyst Blog Highlights: Alphabet, GlaxoSmithKline, T-Mobile, Northrop Grumman and CSX Jul 24 2017
    HIV fight advances with new drug cocktails, fresh vaccine hopes Jul 24 2017
    Top Stock Reports for Alphabet, GlaxoSmithKline & T-Mobile Jul 21 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}